The Effect of Changing Position on Bilirubin Levels in Term Healthy Neonates with Jaundice During Phototherapy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201111063250N4

Enrollment

Registered

2011-12-04

Start date

2011-11-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal jaundice. Neonatal jaundice, unspecified

Interventions

Intervention 1: Intervention group: changing baby position every 150 minutes. Intervention 2: Control group: fix supine position during the study.

Intervention group: changing baby position every 150 minutes

Control group: fix supine position during the study

Eligibility

Sex/Gender

All

Age

3 Years to 10 Years

Inclusion criteria

Inclusion criteria: All term infants weigh more than 2500 gr without congenital malformation with serum bilirubin level 15-23mg/dL are included. Exclusion criteria: age more than 10 days; ABO incompatibility hemolytic jaundice; any signs of infection including sepsis; Serum total Bilirubin concentration above than 23 mg which considered for high intensity phototherapy or blood transfusion.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Total serum bilirubin concentration. Timepoint: hours 6, 12, 18, 24 and 72. Method of measurement: mg/dL using Autoanalyzer.;Duration of phototherapy. Timepoint: hours 6, 12, 18, 24 and 72. Method of measurement: hour.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Bahareh Bahman Bijari

Kerman University of Medical sciences

bbbijari@yahoo.com+98 34 1322 2269

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026